1129P Clinical outcomes from a tebentafusp UK expanded access program in patients with metastatic uveal melanoma (mUM)

Autor: Nathan, P., Tharakan, J.N., Sacco, J.J., Proudfoot-Jones, J., Furness, A., McMahon, D.J., Pallan, L., Khoja, L.T., Serra-Bellver, P., Ranatunge, D., Oladipo, O., Clements, G., Mariappan, L., Talbot, T., Nobes, J., Carter, T.J., Shaw, H.
Zdroj: In Annals of Oncology September 2024 35 Supplement 2:S742-S743
Databáze: ScienceDirect